Literature DB >> 22897950

Markov blanket-based approach for learning multi-dimensional Bayesian network classifiers: an application to predict the European Quality of Life-5 Dimensions (EQ-5D) from the 39-item Parkinson's Disease Questionnaire (PDQ-39).

Hanen Borchani1, Concha Bielza, Pablo Martı Nez-Martı N, Pedro Larrañaga.   

Abstract

Multi-dimensional Bayesian network classifiers (MBCs) are probabilistic graphical models recently proposed to deal with multi-dimensional classification problems, where each instance in the data set has to be assigned to more than one class variable. In this paper, we propose a Markov blanket-based approach for learning MBCs from data. Basically, it consists of determining the Markov blanket around each class variable using the HITON algorithm, then specifying the directionality over the MBC subgraphs. Our approach is applied to the prediction problem of the European Quality of Life-5 Dimensions (EQ-5D) from the 39-item Parkinson's Disease Questionnaire (PDQ-39) in order to estimate the health-related quality of life of Parkinson's patients. Fivefold cross-validation experiments were carried out on randomly generated synthetic data sets, Yeast data set, as well as on a real-world Parkinson's disease data set containing 488 patients. The experimental study, including comparison with additional Bayesian network-based approaches, back propagation for multi-label learning, multi-label k-nearest neighbor, multinomial logistic regression, ordinary least squares, and censored least absolute deviations, shows encouraging results in terms of predictive accuracy as well as the identification of dependence relationships among class and feature variables.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22897950     DOI: 10.1016/j.jbi.2012.07.010

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  7 in total

1.  Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.

Authors:  Nicolas R Thompson; Brittany R Lapin; Irene L Katzan
Journal:  Pharmacoeconomics       Date:  2017-11       Impact factor: 4.981

2.  Probabilistic mapping of the health status measure SF-12 onto the health utility measure EQ-5D using the US-population-based scoring models.

Authors:  Quang A Le
Journal:  Qual Life Res       Date:  2013-09-13       Impact factor: 4.147

3.  Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.

Authors:  Gang Chen; Miguel A Garcia-Gordillo; Daniel Collado-Mateo; Borja Del Pozo-Cruz; José C Adsuar; José Manuel Cordero-Ferrera; José María Abellán-Perpiñán; Fernando Ignacio Sánchez-Martínez
Journal:  Patient       Date:  2018-12       Impact factor: 3.883

4.  Pattern learning reveals brain asymmetry to be linked to socioeconomic status.

Authors:  Timm B Poeppl; Emile Dimas; Katrin Sakreida; Julius M Kernbach; Ross D Markello; Oliver Schöffski; Alain Dagher; Philipp Koellinger; Gideon Nave; Martha J Farah; Bratislav Mišić; Danilo Bzdok
Journal:  Cereb Cortex Commun       Date:  2022-05-20

Review 5.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.

Authors:  Helen Dakin
Journal:  Health Qual Life Outcomes       Date:  2013-09-05       Impact factor: 3.186

6.  Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease.

Authors:  Judith Dams; Jens Klotsche; Bernhard Bornschein; Jens P Reese; Monika Balzer-Geldsetzer; Yaroslav Winter; Anette Schrag; Andrew Siderowf; Wolfgang H Oertel; Günther Deuschl; Uwe Siebert; Richard Dodel
Journal:  Health Qual Life Outcomes       Date:  2013-03-08       Impact factor: 3.186

7.  Sex-Specific Differences in the Association of Metabolically Healthy Obesity With Hyperuricemia and a Network Perspective in Analyzing Factors Related to Hyperuricemia.

Authors:  Simiao Tian; Yazhuo Liu; Ao Feng; Shulong Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-06       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.